Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines

Free Radical Biology and Medicine

Volumn 49, Issue 5, 2010, Pages 908-917

  Yusuf, Mohd A ^a   Chuang, Trinette ^b   Bhat, G Jayarama ^a   Srivenugopal, Kalkunte S ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b MILLIPORE CORPORATION   (United States)

Author keywords

Cancer biomarker; Free radicals; Oxidative stress; P53; Posttranslational modification; Protein glutathionylation; Reactive cysteines; Signaling

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAMPTOTHECIN; CISPLATIN; CYSTEINE; DIAMIDE; DISULFIDE; DOXORUBICIN; HYDROGEN PEROXIDE; MUTANT PROTEIN; POLYCLONAL ANTIBODY; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SCREENING; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CANCER TISSUE; CELL LYSATE; CELL STRAIN HCT116; CELL STRAIN HT29; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; EXPERIMENTAL RABBIT; GLUTATHIONYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RETICULOCYTE; TISSUE MICROARRAY;

ORYCTOLAGUS CUNICULUS;

EID: 77955095138     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.06.020     Document Type: Article

References (50)

1. Lane D.P. Cancer: p53, guardian of the genome. Nature 1992, 358:15-16.
2. Vousden K.H. p53: death star. Cell 2000, 103:691-694.
3. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
4. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
5. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. European Journal of Biochemistry 2001, 268:2764-2772.
6. Bode A.M., Dong Z. Post-translational modification of p53 in tumorigenesis. Nature Reviews. Cancer 2004, 4:793-805.
7. Hainaut P., Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer 1993, 53:4469-4473.
8. Verhaegh G.W., Richard M.J., Hainaut P. Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Molecular and Cellular Biology 1997, 17:5699-5706.
9. Delphin C., Cahen P., Lawrence J.J., Baudier J. Characterization of baculovirus recombinant wild-type p53: dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. European Journal of Biochemistry 1994, 223:683-692.
10. Merwin J.R., Mustacich D.J., Pearson G.D., Merril G.F. Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione. Carcinogenesis 2002, 23:1609-1615.
11. Jayaraman L., Murthy K.G., Zhu C., Curran T., Xanthoudakis S., Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes & Development 1997, 11:558-570.
12. Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. The Journal of Biological Chemistry 1999, 274:35809-35815.
13. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., Mann K. Role of cysteine residues in regulation of p53 function. Molecular and Cellular Biology 1995, 15:3892-3903.
14. Velu C.S., Niture S.K., Doneanu C.E., Pattabiraman N., Srivenugopal K.S. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 2007, 46:7765-7780.
15. Klatt P., Lamas S. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. European Journal of Biochemistry 2000, 267:4928-4944.
16. Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxidants Redox Signaling 2005, 7:964-972.
17. Gallogly M.M., Mieyal J.J. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Current Opinion in Pharmacology 2007, 7:381-391.
18. Augustyn K.E., Merino E.J., Barton J.K. A role for DNA-mediated charge transport in regulating p53: oxidation of the DNA-bound protein from a distance. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:18907-18912.
19. Chen L., Annis I., Barany G. Disulfide bond formation in peptides. Current Protocols in Protein Science 2001, Wiley, New York, Chap. 18, Unit 18.6.
20. Antibodies: a Laboratory Manual 1988, Cold Spring Harbor Laboratory Press, New York. E. Harlow, D.P. Lane (Eds.).
21. Elias J.M. Immunohistochemical methods. Immunohistopathology: a Practical Approach to Diagnosis 2003, 1-110. ASCP Press, Chicago. J.M. Elias (Ed.).
22. Thomas J.A., Mallis R., Sies H. Protein S-thiolation, S-nitrosylation, and irreversible sulfhydryl oxidation: roles in redox regulation. Cellular Implications of Redox Signaling 2003, 141-174. Imperial College Press, London. C. Gitler, A. Danon (Eds.).
23. Reddy S., Jones A.D., Cross C.E., Wong P.S.Y., van der Vliet A. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. The Biochemical Journal 2000, 347:821-827.
24. Brennan J.P., Wait R., Begum S., Bell J.R., Dunn M.J., Eaton P. Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. The Journal of Biological Chemistry 2004, 279:41352-41360.
25. Hough R., Rechsteiner M. Effects of temperature on the degradation of proteins in rabbit reticulocyte lysates and after injection into HeLa cells. Proceedings of the National Academy of Sciences of the United States of America 1984, 81:90-94.
26. Bennett R.G., Hamel F.G., Duckworth W.C. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. Endocrinology 2000, 141:2508-2517.
27. Vojtesek B., Bartek J., Midgley C.A., Lane D.P. An immunological analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. Journal of Immunological Methods 1992, 151:237-244.
28. Bossi G., Lapi E., Strano S., Rinaldo C., Blandino G., Sacchi A. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 2006, 25:304-309.
29. Jarry A., Charrier L., Bou-Hanna C., Devilder M.C., Crussaire V., Denis M.G., Vallette G., Laboisse C.L. Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death. Cancer 2004, 64:4227-4234.
30. Johansson M., Lundberg M. Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochemistry 2007, 8:26.
31. cc, Cronshaw A.D., Harding J.J. The identification of a reaction site of glutathione mixed-disulphide formation on γ S-crystallin in human lens. The Biochemical Journal 2004, 379:595-600.
32. Brennan J.P., Miller J.I.A., Fuller W., Wait R., Begum S., Dunn M.J., Eaton P. The utility of N, N-biotinyl glutathione disulfide in the study of protein S-glutathionylation. Molecular & Cellular Proteomics 2006, 5:215-225.
33. Passarelli C., Di Venere A., Piroddi N., Pastore A., Scellini B., Tesi C., Petrini S., Sale P., Bertini E., Poggesi C. Susceptibility of isolated myofibrils to in vitro glutathionylation: potential relevance to muscle functions. Cytoskeleton 2010, 67:81-89.
34. Benz C.C., Yau C. Ageing, oxidative stress and cancer: paradigms in parallax. Nature Reviews. Cancer 2008, 8:875-879.
35. Trachootham D., Zhang H., Zhang W., Feng L., Du M., Zhou Y., Zhao C., Pelicano H., Plunkett W., Wierda W.G., Keating M.J., Huang P. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood 2008, 112:1912-1922.
36. Liu B., Chen Y., St. Clair D.K. ROS and p53: a versatile partnership. Free Radical Biology & Medicine 2008, 44:1529-1535.
37. Kim G.J., Chandrasekaran K., Morgan W.F. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis 2006, 21:361-367.
38. Humphires K.M., Juliano C., Taylor S.S. Regulation of cAMP-dependant protein kinase activity by glutathionylation. The Journal of Biological Chemistry 2002, 277:43505-43511.
39. Gopalakrishna R., Jaken S. Protein kinase C signaling and oxidative stress. Free Radical Biology & Medicine 2000, 28:1349-1361.
40. Li S., Whorton A.R. Regulation of protein phosphatase 1B in intact cells by S-nitrosothiols. Archives of Biochemistry and Biophysics 2003, 410:269-279.
41. Giustarini D., Milzani Aldini G., Carini M., Rossi R., Dalle-Donne I. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxidants Redox Signaling 2005, 7:930-939.
42. Demasi M., Piassa Fiho G.M., Castro L.M., Ferreira J.C., Rioli V., Ferro E.S. Oligomerization of the cysteinyl-rich oligopeptidase EP24.15 is triggered by S-glutathionylation. Free Radical Biology & Medicine 2008, 44:1180-1190.
43. Findlay V.J., Townsend D.M., Morris T.E., Fraser J.P., He L., Tew K.D. A novel role for sulfiredoxin in the reversal of glutathionylation. Cancer 2006, 66:6800-6806.
44. Minelli A., Bellezza I., Conte C., Culig Z. Oxidative stress-related aging: a role for prostate cancer?. Biochemica et Biophysica Acta 2009, 1795:83-91.
45. Khandrika L., Kumar B., Koul S., Maroni P., Koul H. Oxidative stress in prostate cancer. Cancer 2009, 282:125-136.
46. Lee W.H., Morion R.A., Epstein J.I., Brooks J.D., Campbell P.A., Bova G.S., Hsieh W.S., Issacs W.B., Nelson W.G. Cytidine methylation of regulatory sequences near the Pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:11733-11737.
47. Basu H.S., Thompson T.A., Church D.R., Clower C.C., Mehraein-Ghomi F., Amlong C.A., Martin C.T., Woster P.M., Lindstrom M.J., Wilding G. A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model. Cancer 2009, 69:7689-7695.
48. Cookson M., Reuter V., Linkov I., Fair W. Glutathione S-transferase Pi (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. Journal d'Urologie 1997, 157:673-676.
49. Effert P.J., McCoy R.H., Walther P.J., Liu E.T. p53 gene alterations in human prostate carcinoma. Journal d'Urologie 1993, 150:257-261.
50. Di Domenico F., Cenini G., Sultana R., Perluigi M., Uberti D., Memo M., Butterfield D.A. Glutathionylation of pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochemical Research 2009, 34:727-733.